risedronic acid has been researched along with calcitriol in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (27.27) | 18.2507 |
| 2000's | 5 (45.45) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Boyce, RW; Eriksen, EF; Franks, AF; Jankowsky, ML; Paddock, CL | 1 |
| Funaba, Y; Kawabe, N; Nakadate-Matsushita, T; Tanahashi, M; Tateishi, A | 1 |
| Bekker, PJ; Clemens, TL; Eusebio, RA; Singer, FR | 1 |
| Compston, JE | 1 |
| Erben, RG; Leyshon, A; Mosekilde, L; Phipps, R; Smith, SY; Stahr, K; Thomsen, JS; Weber, K | 1 |
| Mossetti, G; Nunziata, V; Rendina, D; Sorrentino, M; Viceconti, R | 1 |
| Iwamoto, J; Sato, Y; Seki, A; Shen, CL; Takeda, T; Yamada, H; Yeh, JK | 2 |
| Casado-Díaz, A; Dorado, G; Navarro-Valverde, C; Quesada-Gómez, JM; Santiago-Mora, R | 1 |
| Cheung, MS | 1 |
3 review(s) available for risedronic acid and calcitriol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Stimulation of in-vitro angiogenesis by low concentrations of risedronate is mitigated by 1,25-dihydroxyvitamin D3 or 24,25-dihydroxyvitamin D3.
Topics: 24,25-Dihydroxyvitamin D 3; Animals; Bone Density Conservation Agents; Calcitriol; Etidronic Acid; Humans; In Vitro Techniques; Neovascularization, Physiologic; Risedronic Acid | 2015 |
Drugs Used in Paediatric Bone and Calcium Disorders.
Topics: Acetazolamide; Bone and Bones; Bone Density Conservation Agents; Bone Diseases, Metabolic; Calcitonin; Calcitriol; Calcium; Child; Denosumab; Diphosphonates; Diuretics; Glucocorticoids; Humans; Hypercalcemia; Hyperphosphatemia; Hypocalcemia; Hypophosphatemia; Imidazoles; Osteoporosis; Parathyroid Hormone; Phosphates; Risedronic Acid; Sodium Potassium Chloride Symporter Inhibitors; Vitamin D; Zoledronic Acid | 2015 |
8 other study(ies) available for risedronic acid and calcitriol
| Article | Year |
|---|---|
Effects of intermittent hPTH(1-34) alone and in combination with 1,25(OH)(2)D(3) or risedronate on endosteal bone remodeling in canine cancellous and cortical bone.
Topics: Animals; Bone and Bones; Bone Remodeling; Calcitriol; Calcium; Calcium Channel Blockers; Dogs; Drug Therapy, Combination; Etidronic Acid; Humans; Risedronic Acid; Teriparatide | 1996 |
TRK-530 inhibits accumulation of superoxide anions derived from human polymorphonuclear leukocytes and bone resorption induced by activated osteoclasts.
Topics: Animals; Animals, Suckling; Antioxidants; Bone Resorption; Calcitriol; Calcium Channel Blockers; Diphosphonates; Dose-Response Relationship, Drug; Etidronic Acid; Hindlimb; Humans; Mice; N-Formylmethionine Leucyl-Phenylalanine; Neutrophil Activation; Neutrophils; Osteoclasts; Risedronic Acid; Superoxides | 1998 |
Risedronate, a highly effective oral agent in the treatment of patients with severe Paget's disease.
Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Calcitriol; Calcium; Calcium Channel Blockers; Creatinine; Etidronic Acid; Female; Humans; Hydroxyproline; Male; Middle Aged; Osteitis Deformans; Parathyroid Hormone; Phosphorus; Risedronic Acid | 1998 |
Pharmacological interventions for the prevention of vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: does site-specificity exist?
Topics: Aged; Alendronate; Calcitriol; Calcium Channel Agonists; Calcium Channel Blockers; Estrogen Antagonists; Etidronic Acid; Female; Hip Fractures; Humans; Middle Aged; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride; Risedronic Acid; Spinal Fractures | 2000 |
Prevention of bone loss in ovariectomized rats by combined treatment with risedronate and 1alpha,25-dihydroxyvitamin D3.
Topics: Animals; Biomechanical Phenomena; Body Weight; Bone Density; Calcitriol; Etidronic Acid; Female; Osteoporosis; Ovariectomy; Parathyroid Hormone; Rats; Rats, Sprague-Dawley; Risedronic Acid | 2002 |
Risedronate and pamidronate treatment in the clinical management of patients with severe Paget's disease of bone and acquired resistance to bisphosphonates.
Topics: Administration, Oral; Alkaline Phosphatase; Calcitriol; Clodronic Acid; Diphosphonates; Drug Tolerance; Etidronic Acid; Female; Humans; Injections, Intravenous; Male; Middle Aged; Osteitis Deformans; Pain; Pamidronate; Parathyroid Hormone; Risedronic Acid; Treatment Outcome | 2004 |
Comparative effects of risedronate and calcitriol on cancellous bone in rats with glucocorticoid-induced osteopenia.
Topics: Animals; Biomechanical Phenomena; Body Weight; Bone and Bones; Bone Density; Bone Diseases, Metabolic; Bone Remodeling; Bone Resorption; Calcitriol; Calcium; Etidronic Acid; Female; Femur; Phosphorus; Rats; Rats, Sprague-Dawley; Risedronic Acid; Tibia; Tomography, X-Ray Computed | 2006 |
Preventive effects of risedronate and calcitriol on cancellous osteopenia in rats treated with high-dose glucocorticoid.
Topics: Animals; Bone and Bones; Bone Density Conservation Agents; Bone Diseases, Metabolic; Bone Resorption; Calcitriol; Etidronic Acid; Female; Glucocorticoids; Methylprednisolone; Osteogenesis; Random Allocation; Rats; Rats, Sprague-Dawley; Risedronic Acid | 2006 |